SFSerge Finianos

Serge Finianos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Serge Finianos has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differences in Psychological Distress of Cancer and Hemodialysis Caregivers: A Comparative Cross‐Sectional Study in Lebanon

    by Youssef El Toum, Chris Boulos, Tina Haddad, Tarek Costa, Elissa El Toum, Anthony Al Aaraj, Myriam Zarzour, Dania Chelala, Hiba Azar, Serge Finianos, et al.

    Background: Chronic illnesses, such as cancer and end‐stage kidney disease (ESKD), impose significant emotional and physical burdens not only on patients but also on their caregivers. Caregivers play a vital role in providing care, often facing psychological distress, including anxiety and depression, while their quality of life (QoL) may deteriorate. This study aims to compare anxiety, depression, and QoL among caregivers of cancer and ESKD patients in Lebanon. Methods: A cross‐sectional study was conducted with 134 caregivers, including 71 cancer caregivers and 63 hemodialysis caregivers, at the Hôtel Dieu de France University Hospital in Beirut. Participants completed the Hospital Anxiety and Depression Scale (HADS) and the World Health Organization QoL (WHOQoL–BREF) Scale. Results: Caregivers of hemodialysis patients reported significantly lower QoL scores compared to cancer caregivers ( p = 0.0006). Anxiety was prevalent in both groups, with no significant difference in anxiety or depression levels between the two groups. However, caregivers’ educational level ( p = 0.01), anxiety scores ( p = 0.006), and the patient’s comorbidity count ( p = 0.007) significantly predicted QoL. Caregivers with higher education and fewer anxiety symptoms reported better QoL. Conclusion: Caregivers of ESKD patients experience poorer QoL than cancer caregivers, though both groups suffer from high anxiety and depression. To address these disparities, we emphasize the need for universal healthcare coverage, targeted support programs, and routine caregiver well‐being assessments.

  • Open Access

    Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study

    by Jihane Asmar, Dania Chelala, Razane El Hajj Chehade, Hiba Azar, Serge Finianos, Mabel Aoun

    Background: Many studies have assessed the association between anemia and mortality in hemodialysis but few compared patients with and without diabetes. Our study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or without diabetes. Methods: This is a two-center retrospective study that included all adult patients who started hemodialysis between February 2012 and February 2020, followed until January 2021. Averages of hemoglobin, ferritin and transferrin saturation of entire follow-up were recorded. Kaplan Meier survival, log rank test and cox regression analyses were performed to assess the association between anemia biomarkers and mortality. Results: A total of 214 patients were included. Mean age was 67.98 ±12.41 years, mean hemoglobin was 10.92 ±0.75 g/dL, mean ferritin was 504.43 ± 221.42 ng/mL and mean transferrin saturation was 26.23 ±7.77%. Log rank test showed an association between hemoglobin ≥11 g/dL and better survival in patients without diabetes (P = 0.028). Based on cox regression analysis, hemoglobin was associated with all-cause mortality in all patients (HR = 0.66; CI:0.49,0.89; P = 0.007). When comparing patients with and without diabetes, this association remained significant only in patients without diabetes (HR = 0.53; CI:0.37,0.77; P<0.001). Based on different multivariate models, hemoglobin, ferritin and age were independent factors associated with mortality in patients without diabetes. Conclusions: This study showed that hemoglobin ≥11 g/dL is associated with better survival in hemodialysis patients without diabetes but not in those with diabetes. These differences need to be further explored in other countries and settings. An individualization of the hemoglobin target level might be necessary to improve patients’ outcomes.


  • Clinical and histological predictors of long-term kidney graft survival

    by Pierre Galichon, Yi-Chun Xu-Dubois, Serge Finianos, Alexandre Hertig, Eric Rondeau

    Renal transplantation is the best option for patients with end-stage renal disease (ESRD), but its half-life is limited to a decade. Clinical and histological markers measurable within the first year of transplantation can be used to predict its outcome. These markers are important for selecting kidneys for transplantation, for identifying the main causes of late allograft loss, for therapeutic decisions and as surrogate markers in therapeutic trials. ‘Basal state’ markers, such as age, glomerular filtration rate and fibrotic lesions, are highly predictive of allograft loss, showing that early and stable pathological mechanisms contribute considerably to this loss. On the other hand, some more dynamic predictors such as treatment, recurrence of the initial disease, inflammation and epithelial phenotypic changes offer clinicians and researchers opportunities to influence the fate of allografts.